Related references
Note: Only part of the references are listed.Oxyntic gland neoplasm of the stomach: expanding the spectrum and proposal of terminology
Tetsuo Ushiku et al.
MODERN PATHOLOGY (2020)
Reduced αGlcNAc glycosylation on gastric gland mucin is a biomarker of malignant potential for gastric cancer, Barrett's adenocarcinoma, and pancreatic cancer
Kazuhiro Yamanoi et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2018)
Gastric gland mucin-specific O-glycan expression decreases as tumor cells progress from lobular endocervical gland hyperplasia to cervical mucinous carcinoma, gastric type
Kazuhiro Yamanoi et al.
VIRCHOWS ARCHIV (2018)
Gastric gland mucin-specific O-glycan expression decreases with tumor progression from precursor lesions to pancreatic cancer
Ayumi Ohya et al.
CANCER SCIENCE (2017)
Mist1 Expressing Gastric Stem Cells Maintain the Normal and Neoplastic Gastric Epithelium and Are Supported by a Perivascular Stem Cell Niche
Yoku Hayakawa et al.
CANCER CELL (2015)
Decreased expression of gastric gland mucin-specific glycan α1,4-linked N-acetylglucosamine on its scaffold mucin 6 is associated with malignant potential of pyloric gland adenoma of the stomach
Kazuhiro Yamanoi et al.
HISTOPATHOLOGY (2015)
Reduced gland mucin-specific O-glycan in gastric atrophy: A possible risk factor for differentiated-type adenocarcinoma of the stomach
Shigenori Yamada et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Principal cells in gastric neoplasia of fundic gland (chief cell predominant) type show characteristics of immature chief cells
Hiroyoshi Ota et al.
PATHOLOGY INTERNATIONAL (2015)
Dual Roles of Gastric Gland Mucin-specific O-glycans in Prevention of Gastric Cancer
Jun Nakayama
ACTA HISTOCHEMICA ET CYTOCHEMICA (2014)
Loss of gastric gland mucin-specific O-glycan is associated with progression of differentiated-type adenocarcinoma of the stomach
Kazuo Shiratsu et al.
CANCER SCIENCE (2014)
Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum
Akiko Matsubara et al.
JOURNAL OF PATHOLOGY (2013)
Gastric adenocarcinoma of the fundic gland type shares common genetic and phenotypic features with pyloric gland adenoma
Ryoji Kushima et al.
PATHOLOGY INTERNATIONAL (2013)
Essential role of gastric gland mucin in preventing gastric cancer in mice
Fumitoshi Karasawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Japanese classification of gastric carcinoma: 3rd English edition
GASTRIC CANCER (2011)
The Transcription Factor MIST1 Is a Novel Human Gastric Chief Cell Marker Whose Expression Is Lost in Metaplasia, Dysplasia, and Carcinoma
Jochen K. M. Lennerz et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Gastric Adenocarcinoma of Fundic Gland Type (Chief Cell Predominant Type): Proposal for a New Entity of Gastric Adenocarcinoma
Hiroya Ueyama et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Preferential Expression of MUC6 in Oncocytic and Pancreatobiliary Types of Intraductal Papillary Neoplasms Highlights a Pyloropancreatic Pathway, Distinct From the Intestinal Pathway, in Pancreatic Carcinogenesis
Olca Basturk et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Gastric adenocarcinoma with chief cell differentiation
Tetsuya Tsukamoto et al.
PATHOLOGY INTERNATIONAL (2007)
Immunohistochemical demonstration od α,4-N-acetylglucosaminyltransferase that forms GlcNAcα1,4Galβ residues in human gastrointestinal mucosa
MX Zhang et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2001)
Share Paper
